The first-of-its-kind study will evaluate potential association between GSK’s shingles vaccine and reduced dementia risk, building on growing body of evidence from observational and retrospective studies
Alembic Pharmaceuticals successfully completes USFDA inspection for API-III facility
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
Alkem Medtech to acquire 100% stake of Bombay Ortho
USFDA inspection at Alembic Pharma's Bioequivalence facility
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
The PIPE offering consists of 36,190,476 units
USFDA inspection at Emcure Pharmaceuticals API facility
Findings to form the basis for a Phase 3 program, anticipated to start in H2 2025
Cipla Limited has received final approval from the USFDA for the New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’
Subscribe To Our Newsletter & Stay Updated
